Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |